Developer docs
API playgroundTry for free, no card

Search company profiles

Tag.bio

Full company profile

uuid00048gi

Namestring
Tag.bio
Legal namestring
Tag.bio
Websiteurl
tag.bio
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Tag.bio is a San Francisco-based data infrastructure company that has built a composable data mesh platform purpose-built for healthcare and life sciences organizations. The platform's three core products — Data Products, Data Mesh, and Enterprise AI — enable pharmaceutical companies, hospital systems, and research institutions to ingest, harmonize, and analyze complex multi-modal data sources (EHR, clinical trials, genomics, omics, RWE) using domain-specific turnkey archetypes for OMOP, CDISC, and related standards. Data products are harmonized, versioned, containerized, and git-backed units with embedded algorithms and ontology mappings, exposed through a unified Smart API that supports no-code point-and-click analysis as well as R, Python, and SQL access for data scientists.

Underlying the platform is an enterprise AI stack that integrates commercial foundation models (OpenAI, Anthropic Claude, Google Gemini), open-source models (Mistral, Meta Llama, Qwen, DeepSeek), and biology-specialized models (AlphaFold3, ESMFold, ChemBERTa, BioBERT, ClinicalBERT), orchestrated through agentic frameworks (CrewAI, LangGraph, Azure AutoGen Studio) and exposed via Model Context Protocol (MCP) for universal AI-to-data connectivity. The platform ships with built-in CI/CD pipelines, Kubernetes-based deployment, and turnkey onboarding for cloud ML services (Amazon SageMaker, Azure AI, Google Vertex AI), and is itself available through AWS Marketplace and Azure Marketplace.

Tag.bio monetizes through enterprise SaaS subscriptions sold via a consultative direct sales motion — 30-minute demos, pilot project inquiries, and custom annual contracts — targeting large pharmaceutical and biotech firms, hospital systems, and research foundations. Named customers include Pfizer, Regeneron, PPD, UCSF Medical Center, Parkinson's Foundation, and SimpleTherapy, with anonymized references to a Top 10 Pharma and a Large Pharma. The company is privately held and venture-backed by accelerators (Alchemist, Dreamit, StartX, Creative Destruction Lab, PharmStars) and small funds (Merus Capital, Newfund), with a co-founder-led leadership team including CEO Tom Covington, Chief Science Officer Jesse Paquette, and CTO Sanjay Padhi (former Head of AWS Research).

Short descriptiontext

Tag.bio is a San Francisco-based SaaS company that provides a composable data mesh and AI orchestration platform for healthcare and life sciences organizations to harmonize multi-modal clinical, genomics, and RWE data and deploy predictive and agentic AI workflows.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
data mesh platform, healthcare data analytics, biomedical AI platform, clinical data harmonization, life sciences data products
Industry3 codes
PRIMARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACAOAO
Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAAAIAE
AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
NAICS code1 code
  • Software Publishers5132
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Healthcare and Life Sciences Data Platform
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1SaaS Platform Subscription
TypeSubscription Recurring
Description

Tag.bio operates as a SaaS platform providing subscription-based access to its data mesh and AI platform for healthcare and life sciences organizations. The platform is available through direct procurement and cloud marketplaces (AWS, Azure), suggesting a subscription pricing model with enterprise contracts. Pilot projects and demos are offered as engagement entry points.

tag.bio
2Marketplace Transactions
TypeSubscription Recurring
Description

Availability in AWS Marketplace and Azure Marketplace may enable usage-based or transactional procurement through cloud billing infrastructure.

tag.bio
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Enterprise platform subscription — no public pricing disclosed
ModelSubscriptionBilling cadenceAnnual
Notes

Pricing is not publicly disclosed. Tag.bio engages prospective customers through 30-minute product demos and pilot project inquiries, indicating a consultative, custom-quote enterprise sales process.

tag.bio
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Tag.bio provides a composable data mesh platform for healthcare and life sciences organizations. The platform enables users to instantiate governed, versioned, containerized data products from disparate sources (EHR, OMOP, CDISC, omics, RWE), expose them through harmonized Smart APIs, and build predictive and generative AI applications including agentic AI workflows. It is sold primarily as an enterprise SaaS subscription, deployable on AWS, Azure, GCP or hybrid/on-prem environments.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Tag.bio is a composable data mesh platform comprising three core integrated products: Data Products (harmonized, versioned, containerized data units as the fundamental building block), Data Mesh (network of interconnected data products providing scalability and FAIR-compliant APIs), and Enterprise AI (predictive and generative AI solution with agentic capabilities). Additional modules include Low-code Data Preparation (data ingestion and modeling with turnkey archetypes), Harmonized API Access (universal API layer for no-code and code-based access), Embedded & Customized Algorithms (pro-code algorithm implementation), and the Agentic AI Platform (autonomous AI agents for life sciences workflows). The platform is deployed as a managed SaaS solution with support for AWS, Azure, and GCP cloud environments.

Product and service4 records
1Data Products
CategoryCore Platform Module
Description

Composable, harmonized, versioned, containerized and git-backed data products that merge multi-modal data sources (OMOP, CDISC, EHR, RWE, DNA-Seq, RNA-Seq) into simplified data models with ontology mappings, designed for healthcare and life sciences data teams.

2Data Mesh
CategoryCore Platform Module
Description

Network of interconnected, FAIR-compliant data products providing scalability, orchestration, distribution, CI/CD and governance across cloud (AWS, Azure, GCP), hybrid and on-prem environments for healthcare and life sciences organizations.

3Enterprise AI
CategoryCore Platform Module
Description

Unified AI capability for building, fine-tuning and deploying predictive and generative AI projects on healthcare and life sciences data, with containerized private model registries, a developer studio and integrations with Amazon SageMaker, Microsoft Azure AI and Google Vertex AI.

4Agentic AI Platform
CategoryCore Platform Module
Description

Platform for deploying autonomous AI agents in life sciences workflows, with multi-agent orchestration via CrewAI and LangGraph, Model Context Protocol integration for universal data connectivity, Agent-to-Agent communication, biology-specialized agent models and Federated Agent Networks operating across institutional boundaries.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-04-17
Description

Tag.bio and SimpleTherapy partnered to bring transparency in precision medicine for MSK (musculoskeletal) issues, which significantly impact employers and health plans due to increased healthcare costs and reduced employee productivity.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-11-16
Description

Parkinson's Foundation and Tag.bio partnered to enable researchers across organizations to securely analyze and share anonymized data combining clinical and genomics data sets, accelerating research and driving insights into Parkinson's disease.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

L7 Informatics is integrating Tag.bio's data mesh platform into its 'life-leading unified platform,' L7|ESP, and offering it to all existing and new customers. A virtual data mesh provides the best strategy to provide L7's customers with harmonized, governed data access.

Strategic tierIntegration PartnerTypeTechnology or Integration
Description

Tag.bio is available in AWS Marketplace and integrates with AWS cloud infrastructure for secure compute environment deployment of data products. Amazon is also listed as an investor in Tag.bio.

5Microsoft Azure
Strategic tierIntegration PartnerTypeTechnology or Integration
Description

Tag.bio is available in Azure Marketplace and integrates with Microsoft Azure AI and cloud infrastructure. Microsoft is also listed as an investor in Tag.bio.

tag.bio
Strategic tierIntegration PartnerTypeTechnology or Integration
Description

Tag.bio integrates with Google Cloud infrastructure and Google Vertex AI for AI/ML deployment. Google is also listed as an investor in Tag.bio.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Cloud-based biomedical data analysis and management platform serving pharma, clinical labs, and consortia. Directly comparable to Tag.bio as it provides harmonized genomics and clinical data backends with similar target customers and marketplace integrations.

TypeBroad incumbent
Description

Dominant life sciences cloud platform spanning commercial, clinical, regulatory, and quality. While narrower on data mesh, Veeva overlaps with Tag.bio on harmonized data products for clinical and commercial operations at large pharma customers.

TypeDirect peer
Description

Scientific R&D informatics platform spanning lab data, ELN, and analytics for pharma and biotech. Comparable to Tag.bio on the scientific data management and harmonization layer for R&D-intensive customers.

TypeDirect peer
Description

Scientific data cloud that harmonizes R&D data from lab instruments and enterprise systems for life sciences customers. Competes with Tag.bio on the data harmonization layer for pharma/biotech R&D workflows, with a similar industry vertical focus.

TypeBroad incumbent
Description

Broader lakehouse/data intelligence platform with a dedicated Healthcare & Life Sciences vertical offering data products, ML/AI tooling, and marketplace harmonized datasets. Competes with Tag.bio at the platform layer while addressing a much wider enterprise customer base.

TypeDirect peer
Description

Biomedical data analysis platform for genomics, multi-omics, and clinical research. Directly comparable to Tag.bio in providing data harmonization and analytics infrastructure to pharma, academic consortia, and clinical research customers.

TypeBroad incumbent
Description

Cloud data warehouse with a Healthcare & Life Sciences Data Cloud, secure data sharing, and pre-built HLS datasets. Competes with Tag.bio on the harmonization and analytics layer and is one of Tag.bio's integrated data sources.

TypeBroad incumbent
Description

Enterprise data integration and analytics platform with significant presence in pharma R&D, clinical operations, and government health. Competes with Tag.bio on harmonizing and operationalizing complex multi-modal data at large health and life sciences organizations.

TypeDirect peer
Description

Provider of the L7|ESP unified life sciences platform, which is actively integrating Tag.bio's data mesh. Both companies target the same HLS enterprise customers with harmonized data product concepts; the partnership makes them both collaborators and adjacent competitors.

TypeBroad incumbent
Description

AWS's HIPAA-eligible managed services for storing, transforming, and querying healthcare and omics data. Directly comparable to Tag.bio's underlying harmonization capabilities and bundled with the broader AWS ecosystem that also distributes Tag.bio via AWS Marketplace.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration31 records

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds10 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Tag.bio

Healthcare and Life Sciences Data Platformtag.bio

Tag.bio is a San Francisco-based SaaS company that provides a composable data mesh and AI orchestration platform for healthcare and life sciences organizations to harmonize multi-modal clinical, genomics, and RWE data and deploy predictive and agentic AI workflows.

What Tag.bio does

Tag.bio is a San Francisco-based data infrastructure company that has built a composable data mesh platform purpose-built for healthcare and life sciences organizations. The platform's three core products — Data Products, Data Mesh, and Enterprise AI — enable pharmaceutical companies, hospital systems, and research institutions to ingest, harmonize, and analyze complex multi-modal data sources (EHR, clinical trials, genomics, omics, RWE) using domain-specific turnkey archetypes for OMOP, CDISC, and related standards. Data products are harmonized, versioned, containerized, and git-backed units with embedded algorithms and ontology mappings, exposed through a unified Smart API that supports no-code point-and-click analysis as well as R, Python, and SQL access for data scientists.

Underlying the platform is an enterprise AI stack that integrates commercial foundation models (OpenAI, Anthropic Claude, Google Gemini), open-source models (Mistral, Meta Llama, Qwen, DeepSeek), and biology-specialized models (AlphaFold3, ESMFold, ChemBERTa, BioBERT, ClinicalBERT), orchestrated through agentic frameworks (CrewAI, LangGraph, Azure AutoGen Studio) and exposed via Model Context Protocol (MCP) for universal AI-to-data connectivity. The platform ships with built-in CI/CD pipelines, Kubernetes-based deployment, and turnkey onboarding for cloud ML services (Amazon SageMaker, Azure AI, Google Vertex AI), and is itself available through AWS Marketplace and Azure Marketplace.

Tag.bio monetizes through enterprise SaaS subscriptions sold via a consultative direct sales motion — 30-minute demos, pilot project inquiries, and custom annual contracts — targeting large pharmaceutical and biotech firms, hospital systems, and research foundations. Named customers include Pfizer, Regeneron, PPD, UCSF Medical Center, Parkinson's Foundation, and SimpleTherapy, with anonymized references to a Top 10 Pharma and a Large Pharma. The company is privately held and venture-backed by accelerators (Alchemist, Dreamit, StartX, Creative Destruction Lab, PharmStars) and small funds (Merus Capital, Newfund), with a co-founder-led leadership team including CEO Tom Covington, Chief Science Officer Jesse Paquette, and CTO Sanjay Padhi (former Head of AWS Research).

Tag.bio firmographics

Firmographics
Name
Tag.bio
Legal name
Tag.bio
Website
https://tag.bio
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
1–10 employees
Short description
Tag.bio is a San Francisco-based SaaS company that provides a composable data mesh and AI orchestration platform for healthcare and life sciences organizations to harmonize multi-modal clinical, genomics, and RWE data and deploy predictive and agentic AI workflows.
Ownership category
akta.pro rank

Tag.bio industry classification

Industry
Product category
Healthcare and Life Sciences Data Platform
NAICS
Software Publishers (5132)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACAOAO
Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAAAIAE
AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)

Keywords

  • Data mesh platform
  • Healthcare data analytics
  • Biomedical AI platform
  • Clinical data harmonization
  • Life sciences data products

Where Tag.bio is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Tag.bio business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. SaaS Platform Subscription: Tag.bio operates as a SaaS platform providing subscription-based access to its data mesh and AI platform for healthcare and life sciences organizations. The platform is available through direct procurement and cloud marketplaces (AWS, Azure), suggesting a subscription pricing model with enterprise contracts. Pilot projects and demos are offered as engagement entry points.
  2. Marketplace Transactions: Availability in AWS Marketplace and Azure Marketplace may enable usage-based or transactional procurement through cloud billing infrastructure.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise platform subscription — no public pricing disclosed

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Tag.bio product offering

Product offering

Core offering

Tag.bio provides a composable data mesh platform for healthcare and life sciences organizations. The platform enables users to instantiate governed, versioned, containerized data products from disparate sources (EHR, OMOP, CDISC, omics, RWE), expose them through harmonized Smart APIs, and build predictive and generative AI applications including agentic AI workflows. It is sold primarily as an enterprise SaaS subscription, deployable on AWS, Azure, GCP or hybrid/on-prem environments.

Product overview

Tag.bio is a composable data mesh platform comprising three core integrated products: Data Products (harmonized, versioned, containerized data units as the fundamental building block), Data Mesh (network of interconnected data products providing scalability and FAIR-compliant APIs), and Enterprise AI (predictive and generative AI solution with agentic capabilities). Additional modules include Low-code Data Preparation (data ingestion and modeling with turnkey archetypes), Harmonized API Access (universal API layer for no-code and code-based access), Embedded & Customized Algorithms (pro-code algorithm implementation), and the Agentic AI Platform (autonomous AI agents for life sciences workflows). The platform is deployed as a managed SaaS solution with support for AWS, Azure, and GCP cloud environments.

Differentiator

Problem solved

Functional benefit

Products and services

  • Data Products Composable, harmonized, versioned, containerized and git-backed data products that merge multi-modal data sources (OMOP, CDISC, EHR, RWE, DNA-Seq, RNA-Seq) into simplified data models with ontology mappings, designed for healthcare and life sciences data teams.
  • Data Mesh Network of interconnected, FAIR-compliant data products providing scalability, orchestration, distribution, CI/CD and governance across cloud (AWS, Azure, GCP), hybrid and on-prem environments for healthcare and life sciences organizations.
  • Enterprise AI Unified AI capability for building, fine-tuning and deploying predictive and generative AI projects on healthcare and life sciences data, with containerized private model registries, a developer studio and integrations with Amazon SageMaker, Microsoft Azure AI and Google Vertex AI.
  • Agentic AI Platform Platform for deploying autonomous AI agents in life sciences workflows, with multi-agent orchestration via CrewAI and LangGraph, Model Context Protocol integration for universal data connectivity, Agent-to-Agent communication, biology-specialized agent models and Federated Agent Networks operating across institutional boundaries.

Companies that use Tag.bio

Customer profile

Named customers8 records

Segments3 records

Ideal customer profiles3 records

Tag.bio technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration31 records

AI capability7 records

Feature10 records

Tag.bio partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and integration partner.

  • SimpleTherapycoreStrategic or Co-development Partner · 17 April 2023Tag.bio and SimpleTherapy partnered to bring transparency in precision medicine for MSK (musculoskeletal) issues, which significantly impact employers and health plans due to increased healthcare costs and reduced employee productivity.
  • Parkinson's FoundationcoreStrategic or Co-development Partner · 16 November 2022Parkinson's Foundation and Tag.bio partnered to enable researchers across organizations to securely analyze and share anonymized data combining clinical and genomics data sets, accelerating research and driving insights into Parkinson's disease.
  • L7 InformaticscoreStrategic or Co-development PartnerL7 Informatics is integrating Tag.bio's data mesh platform into its 'life-leading unified platform,' L7|ESP, and offering it to all existing and new customers. A virtual data mesh provides the best strategy to provide L7's customers with harmonized, governed data access.
  • Amazon (AWS)integration partnerTechnology or IntegrationTag.bio is available in AWS Marketplace and integrates with AWS cloud infrastructure for secure compute environment deployment of data products. Amazon is also listed as an investor in Tag.bio.
  • Microsoft Azureintegration partnerTechnology or IntegrationTag.bio is available in Azure Marketplace and integrates with Microsoft Azure AI and cloud infrastructure. Microsoft is also listed as an investor in Tag.bio.
  • Google Cloudintegration partnerTechnology or IntegrationTag.bio integrates with Google Cloud infrastructure and Google Vertex AI for AI/ML deployment. Google is also listed as an investor in Tag.bio.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Tag.bio competitors and assessment

Company assessment

Direct peers

  • DNAnexus: Cloud-based biomedical data analysis and management platform serving pharma, clinical labs, and consortia. Directly comparable to Tag.bio as it provides harmonized genomics and clinical data backends with similar target customers and marketplace integrations.
  • Dotmatics: Scientific R&D informatics platform spanning lab data, ELN, and analytics for pharma and biotech. Comparable to Tag.bio on the scientific data management and harmonization layer for R&D-intensive customers.
  • TetraScience: Scientific data cloud that harmonizes R&D data from lab instruments and enterprise systems for life sciences customers. Competes with Tag.bio on the data harmonization layer for pharma/biotech R&D workflows, with a similar industry vertical focus.
  • Seven Bridges / Velsera: Biomedical data analysis platform for genomics, multi-omics, and clinical research. Directly comparable to Tag.bio in providing data harmonization and analytics infrastructure to pharma, academic consortia, and clinical research customers.
  • L7 Informatics: Provider of the L7|ESP unified life sciences platform, which is actively integrating Tag.bio's data mesh. Both companies target the same HLS enterprise customers with harmonized data product concepts; the partnership makes them both collaborators and adjacent competitors.

Broad incumbents

  • Veeva Systems: Dominant life sciences cloud platform spanning commercial, clinical, regulatory, and quality. While narrower on data mesh, Veeva overlaps with Tag.bio on harmonized data products for clinical and commercial operations at large pharma customers.
  • Databricks: Broader lakehouse/data intelligence platform with a dedicated Healthcare & Life Sciences vertical offering data products, ML/AI tooling, and marketplace harmonized datasets. Competes with Tag.bio at the platform layer while addressing a much wider enterprise customer base.
  • Snowflake: Cloud data warehouse with a Healthcare & Life Sciences Data Cloud, secure data sharing, and pre-built HLS datasets. Competes with Tag.bio on the harmonization and analytics layer and is one of Tag.bio's integrated data sources.
  • Palantir Foundry: Enterprise data integration and analytics platform with significant presence in pharma R&D, clinical operations, and government health. Competes with Tag.bio on harmonizing and operationalizing complex multi-modal data at large health and life sciences organizations.
  • AWS HealthLake / HealthOmics: AWS's HIPAA-eligible managed services for storing, transforming, and querying healthcare and omics data. Directly comparable to Tag.bio's underlying harmonization capabilities and bundled with the broader AWS ecosystem that also distributes Tag.bio via AWS Marketplace.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Tag.bio social profiles

Digital presence

Tag.bio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Tag.bio leadership team

Management profile

Number of profiles

Profiles4 records

Tag.bio funding detail

Funding detail

Funding overview

Funding rounds10 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Tag.bio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tag.bio

What does Tag.bio do?

Tag.bio provides a composable data mesh platform for healthcare and life sciences organizations. The platform enables users to instantiate governed, versioned, containerized data products from disparate sources (EHR, OMOP, CDISC, omics, RWE), expose them through harmonized Smart APIs, and build predictive and generative AI applications including agentic AI workflows. It is sold primarily as an enterprise SaaS subscription, deployable on AWS, Azure, GCP or hybrid/on-prem environments.

Is Tag.bio a public or private company?

Tag.bio is a private company. It is classified as venture growth investor backed and is currently operating.

When was Tag.bio founded?

Tag.bio was founded in 2013. It employs 1 to 10 people.

Where is Tag.bio based?

Tag.bio is headquartered in San Francisco, United States, in the North America region.

How does Tag.bio make money?

Two revenue lines are on record. SaaS Platform Subscription is the primary driver. The others are marketplace Transactions.

Who are Tag.bio's main competitors?

Direct peers on record are DNAnexus, Dotmatics, TetraScience, Seven Bridges / Velsera and L7 Informatics. Broad incumbents are Veeva Systems, Databricks, Snowflake, Palantir Foundry and AWS HealthLake / HealthOmics.

Does Tag.bio have an API?

Yes. Tag.bio offers a Smart API that enables universal data product access. The API supports REST endpoints, SQL API for data analysts and BI tools, and R & Python SDKs for data scientists. Smart APIs combine datasets, algorithms, R/Python scripts, and analysis workflows into callable API methods. The platform supports JSON and YAML for configuration. APIs provide reproducible, point-and-click analysis capabilities, and data frame extraction for ad-hoc analysis, visualization, and ML model building. Model Context Protocol (MCP) integration is explicitly mentioned for universal data connectivity.

What industry is Tag.bio in?

Tag.bio's product category is Healthcare and Life Sciences Data Platform. Its primary akta.pro industry code is HLAGAJAC, Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D), with a secondary code of HLACAOAO, Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines). Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogTag.bio and SimpleTherapy® Partner to Bring Transparency in Precision MedicineTag.bio and SimpleTherapy announced a partnership to combine data mesh analytics with personalized MSK and behavioral health care. The collaboration aims to improve diagnostic accuracy, treatment effectiveness, and reduce healthcare costs. Both companies cited precision medicine as a key driver for the alliance.Business Wire BlogTag.bio and SimpleTherapy® Partner to Bring Transparency in Precision MedicineTag.bio and SimpleTherapy announced a partnership to improve patient diagnoses and reduce healthcare costs through data mesh analytics. The collaboration aims to personalize MSK and behavioral health treatments, with SimpleTherapy integrating Tag.bio's platform to evaluate cost and outcome impacts.PR NewswireL7 and Tag.bio Team Up to Accelerate Digital TransformationL7 Informatics and Tag.bio have formed a partnership aimed at enhancing digital transformation in life sciences by integrating Tag.bio's data mesh platform into L7's L7|ESP platform. This integration is intended to support real-time decision-making and help customers optimize their data utilization. The collaboration is positioned to assist organizations in adapting to increasing demands in various sectors, including pharmaceutical and biotechnology fields.PrwebTag.bio Launches To Make Everyone a Data ScientistTag.bio, a data analytics company, announced its beta launch on January 22, 2016, offering an online platform for anyone to analyze big data. The platform couples analytics with human intelligence, with first public datasets from NFL and MLB. It plans to offer a software development kit and developer community resources.